Sanyou Bio Enters into Collaboration with Shanghai ZJ Bio-Tech to Advance Automated Development of Innovative Biologics
Tuesday, November 04, 2025
Sanyou Biopharmaceuticals and Shanghai ZJ Bio-Tech Technology have entered into a strategic cooperation agreement focused on the automated development of innovative biologics.
The partnership aims to overcome research and development (R&D) challenges and accelerate drug discovery through the integration of automation technologies.
Under the agreement, Sanyou Bio will enhance its R&D process by incorporating automated systems designed to shorten the development cycle of new drugs. The use of automation is expected to improve efficiency, optimise resource allocation, and allow researchers to focus on innovation. The upgraded processes will also improve accuracy and consistency, leading to better utilisation of R&D budgets.
Beyond reducing timelines, this collaboration seeks to strengthen the predictability and productivity of the R&D process. The partnership will combine advanced technologies and strategic expertise to promote scientific innovation and support the development of next-generation antibody drugs and diagnostic solutions within the broader framework of intelligent healthcare.
The cooperation will bring together Sanyou Bio’s AI-powered Super-Trillion Molecule Library (AI-STAL) technology and its experience in intelligent drug screening with Shanghai ZJ Bio-Tech’s automated smart systems. This integration is expected to significantly accelerate drug development and enhance technological innovation in biologics research.
Through this alliance, both organisations aim to establish a more efficient and intelligent R&D ecosystem, enabling faster progress from laboratory discovery to clinical application and contributing to global efforts in advancing innovative therapies.
Source: prnewswire.com
